Assembly Biosciences (ASMB) Free Cash Flow (2010 - 2026)
Assembly Biosciences (ASMB) posted quarterly Free Cash Flow of -$22.1 million for Q1 2026, up 5.64% year-over-year from -$20.9 million in Q1 2025, and down 255.6% quarter-over-quarter from $14.2 million in Q4 2025.
Assembly Biosciences (ASMB) Free Cash Flow (2010 - 2026) Analysis & Trends
Assembly Biosciences' Free Cash Flow history runs 17 years deep, the most recent figure standing at -$22.1 million for Q1 2026.
- In Q1 2026, Free Cash Flow rose 5.64% year-over-year to -$22.1 million; the TTM figure through Mar 2026 stood at -$39.8 million (up 29.13% YoY), while the FY2025 annual figure was -$41.2 million, up 19.52% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$22.1 million, down from $14.2 million in the prior quarter.
- The five-year high for Free Cash Flow was $74.4 million in Q4 2023, with the low at -$28.0 million in Q1 2022.
- The 5-year median for Free Cash Flow is -$17.1 million (2024), against an average of -$10.3 million.
- The sharpest annual moves came in 2024 and 2025: Free Cash Flow slumped 100.55% in 2024, then surged 3592.14% in 2025.
- Assembly Biosciences' Free Cash Flow stood at -$18.3 million in 2022, then surged by 505.76% to $74.4 million in 2023, then plunged by 100.55% to -$407000.0 in 2024, then soared by 3592.14% to $14.2 million in 2025, then tumbled by 255.6% to -$22.1 million in 2026.
- Business Quant data shows ASMB's Free Cash Flow at -$22.1 million in Q1 2026, $14.2 million in Q4 2025, and -$15.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -389.61 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 437.80 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2.33 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 477.44 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 292.04 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -95.09 Mn |
| 10 | Assembly Biosciences | 670.88 Mn | 350.52 Mn | - | -15.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -15.59 Mn |
| Jun 30, 2026 | -15.59 Mn |
| Mar 31, 2026 | -22.12 Mn |
| Mar 31, 2026 | -22.12 Mn |
| Dec 31, 2025 | 14.21 Mn |
| Dec 31, 2025 | 14.21 Mn |
| Sep 30, 2025 | -15.18 Mn |
| Sep 30, 2025 | -15.18 Mn |
| Jun 30, 2025 | -16.76 Mn |
| Jun 30, 2025 | -16.76 Mn |
| Mar 31, 2025 | -23.44 Mn |
| Mar 31, 2025 | -23.44 Mn |
| Dec 31, 2024 | -407,000.00 |
| Dec 31, 2024 | -407,000.00 |
| Sep 30, 2024 | -15.24 Mn |
| Sep 30, 2024 | -15.24 Mn |
| Jun 30, 2024 | -17.12 Mn |
| Jun 30, 2024 | -17.12 Mn |
| Mar 31, 2024 | -18.38 Mn |
| Mar 31, 2024 | -18.38 Mn |